Test Module 2

The World Health Organization (WHO) has launched target product profiles to drive the rapid development of novel tuberculosis (TB) preventive treatment today. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.

One quarter of the global population is estimated to be infected with TB and are at greater risk of developing TB disease, especially those with weakened immunity. Treatment of T

Roles: Everyone: All Users

Regions: Canada , France , Italy , United Kingdom

Topics: Global Health

• Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC)
• The COVAX Facility, and the AMC within it, is designed to guarantee rapid, fair and equitable access to COVID-19 vaccines for every country in the world, rich and poor, to make rapid progress towards slowing the pandemic 
  
• Interest from governments represen

  Roles: Everyone: All Users

  Regions: Argentina, Canada , Norway , United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

• Public statement for collaboration on COVID-19 vaccine development

  Roles: Everyone: All Users

  Regions: Argentina, Canada , Chad , China, Norway , United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

• WHO and Global Citizen announce: 'One World: Together at home' Global Special to support healthcare workers in the fight against the COVID-19 pandemic

  Roles: Everyone: All Users

  Regions: Canada , United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation